Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-108.41%
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-100.48%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -108.41% |
| 2023 | -193.03% |
| 2022 | 0.00% |